APOTHEEK VELTEM_PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK VELTEM_PHARMA
Largest movements
- Cash +€66,629
up €66,629 (+32.7%), from €204,038 to €270,667
mainly Net result for the year (+€167,043) and Depreciation (+€62,894)
- Receivables within one year +€32,144
up €32,144 (+19.0%), from €168,862 to €201,006
of which Trade receivables: +€29,745
- Tangible fixed assets +€25,854
up €25,854 (+3.2%), from €819,856 to €845,709
of which Land and buildings: +€41,888
- Stocks and contracts -€19,187
down €19,187 (-6.8%), from €282,286 to €263,099
- Reserves +€67,043
up €67,043 (+8.5%), from €790,618 to €857,661
of which Distributable reserves: +€67,043
- Debts after one year -€41,464
down €41,464 (-10.3%), from €403,765 to €362,301
- Trade debts +€39,829
up €39,829 (+54.2%), from €73,522 to €113,351
- Other debts +€25,000
up €25,000 (+33.3%), from €75,000 to €100,000
- Gross operating margin -€42,369
down €42,369 (-9.1%), from €468,022 to €425,653
- Other operating charges -€25,776
down €25,776 (-82.1%), from €31,378 to €5,601
- Depreciation +€18,133
up €18,133 (+40.5%), from €44,761 to €62,894
- Staff costs +€10,241
up €10,241 (+9.9%), from €103,898 to €114,139
- Taxes -€5,233
down €5,233 (-9.0%), from €58,002 to €52,770
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,480,334 | €1,585,275 | +€104,942 | +7.1% |
| Fixed assets | 21/28 | €820,706 | €846,559 | +€25,854 | +3.2% |
| Tangible fixed assets | 22/27 | €819,856 | €845,709 | +€25,854 | +3.2% |
| Land and buildings | 22 | €700,072 | €741,960 | +€41,888 | +6.0% |
| Plant, machinery and equipment | 23 | €39,921 | €15,343 | -€24,578 | -61.6% |
| Furniture and vehicles | 24 | €1,714 | €14,460 | +€12,747 | +744% |
| Other tangible fixed assets | 26 | €78,149 | €73,946 | -€4,203 | -5.4% |
| Financial fixed assets | 28 | €850 | €850 | = | 0.0% |
| Current assets | 29/58 | €659,628 | €738,716 | +€79,088 | +12.0% |
| Stocks and contracts in progress | 3 | €282,286 | €263,099 | -€19,187 | -6.8% |
| Stocks | 30/36 | €282,286 | €263,099 | -€19,187 | -6.8% |
| Amounts receivable within one year | 40/41 | €168,862 | €201,006 | +€32,144 | +19.0% |
| Trade receivables | 40 | €162,033 | €191,778 | +€29,745 | +18.4% |
| Other amounts receivable | 41 | €6,829 | €9,228 | +€2,399 | +35.1% |
| Cash at bank and in hand | 54/58 | €204,038 | €270,667 | +€66,629 | +32.7% |
| Deferred charges and accrued income | 490/1 | €4,442 | €3,943 | -€498 | -11.2% |
| Total equity and liabilities | 10/49 | €1,480,334 | €1,585,275 | +€104,942 | +7.1% |
| Equity | 10/15 | €852,618 | €919,661 | +€67,043 | +7.9% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €790,618 | €857,661 | +€67,043 | +8.5% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €784,418 | €851,461 | +€67,043 | +8.5% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €627,716 | €665,614 | +€37,898 | +6.0% |
| Amounts payable after more than one year | 17 | €403,765 | €362,301 | -€41,464 | -10.3% |
| Financial debts | 170/4 | €403,765 | €362,301 | -€41,464 | -10.3% |
| Amounts payable within one year | 42/48 | €219,751 | €299,114 | +€79,362 | +36.1% |
| Current portion of amounts payable after more than one year | 42 | €58,582 | €60,115 | +€1,533 | +2.6% |
| Trade debts | 44 | €73,522 | €113,351 | +€39,829 | +54.2% |
| Suppliers | 440/4 | €73,522 | €113,351 | +€39,829 | +54.2% |
| Taxes, remuneration and social security | 45 | €12,647 | €25,647 | +€13,000 | +103% |
| Taxes | 450/3 | €0 | €3,793 | +€3,793 | |
| Remuneration and social security | 454/9 | €12,647 | €21,854 | +€9,207 | +72.8% |
| Other amounts payable | 47/48 | €75,000 | €100,000 | +€25,000 | +33.3% |
| Accrued charges and deferred income | 492/3 | €4,200 | €4,200 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €103,898 | €114,139 | +€10,241 | +9.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €44,761 | €62,894 | +€18,133 | +40.5% |
| Other operating charges | 640/8 | €31,378 | €5,601 | -€25,776 | -82.1% |
| Gross operating margin | 9900 | €468,022 | €425,653 | -€42,369 | -9.1% |
| Operating profit (loss) | 9901 | €287,986 | €243,018 | -€44,967 | -15.6% |
| Financial income | 75/76B | €2,981 | €4,892 | +€1,911 | +64.1% |
| Recurring financial income | 75 | €2,981 | €4,892 | +€1,911 | +64.1% |
| Financial charges | 65/66B | €23,670 | €28,097 | +€4,427 | +18.7% |
| Recurring financial charges | 65 | €23,670 | €28,097 | +€4,427 | +18.7% |
| Profit (loss) for the period before taxes | 9903 | €267,296 | €219,813 | -€47,483 | -17.8% |
| Income taxes | 67/77 | €58,002 | €52,770 | -€5,233 | -9.0% |
| Profit (loss) for the period | 9904 | €209,294 | €167,043 | -€42,251 | -20.2% |
| Profit (loss) for the period to be appropriated | 9905 | €209,294 | €167,043 | -€42,251 | -20.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.